Navigation Links
Sangui and SastoMed Complement Licensing Agreement in View of Increasing Sales Success
Date:8/27/2012

WITTEN, Germany, August 27, 2012 /PRNewswire/ --

Sangui BioTech GmbH and SastoMed GmbH cordially adjusted the existing sales strategy as the introduction of Granulox to professional circles proves to be increasingly successful. In consideration of corresponding contributions the existing licensing contract was partially complemented resulting in the following conditions:

As licensor SanguiBioTech GmbH is awarded a fixed licensing fee as a percentage of each and every external revenues incurred by SastoMed from sales of the Granulox product (based on SastoMed selling prices). The percentage ranges in the uppermost zone of what is usually granted in the pharmaceutical and medical products industries and thus well above the average licensing rate of 7.5% of sales revenues as calculated by market analysts. In addition and complementing this basic agreement the percentage will be permanently increased by one fourth of the current rate as soon as cumulated sales revenues at SastoMed will have exceeded the total of €50,000,000.

As shareholder SanguiBioTech GmbH will benefit additionally from all future dividends to be paid by the subsidiary according to the percentage of its stake in SastoMed that is at a rate of 25%. Should eventually all the shares of SastoMed GmbH be sold in total to a third party, the existing licensing contract with SanguiBioTech GmbH will persist unchanged.

"This amendment of our licensing contract", emphasized Hubertus Schmelz, Managing Director of SanguiBioTech GmbH, "is another token of the close and cordial cooperation based on mutual trust and aiming at our joint success. Our business model proves its worth not least because of the professional and effective work of our partners which meets our support in every respect."

Sangui BioTech International, Inc. ("SGBI") is a holding company the shares of which are being traded on the OTCQB marketplace (http://www.otcmarket
'/>"/>

SOURCE Sangui Bio Tech International Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Mexican State of Tamaulipas Starts Training Doctors in Sangui Wound Management
2. CE Mark Granted for Wound Spray Based on Sangui Patent
3. Sangui Bio Tech International Inc. - Over 500 Customers: Granulox Sales Ahead of Planning
4. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
5. Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology
6. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
7. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
8. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
9. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
10. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
11. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 24, 2013 In a sneak ... suppliers will present technologies with applications in multiple ... SPIE Optics and Photonics symposium in ... SPIE, the international society for optics and photonics ... optical sciences and technology meeting in North America, ...
(Date:5/24/2013)... , May 24, 2013 Senomyx ... using proprietary taste science technologies to discover, develop, and ... David Linemeyer , Ph.D., the Company,s Vice President, ... President, Investor Relations & Corporate Communications, will present an ... 31, at 10:25 a.m. Eastern Time (7:25 a.m. Pacific ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The Oklahoma ... And following its ravage, the mayor of Moore, one of ... new houses, said a report from cnn.com. Reaching out to ... victims complimentary Molderizer and Safe Shield to counter the looming ... report published on May 22, 2013, caused 24 deaths, My ...
(Date:5/23/2013)... May 24, 2013 Die Übersetzungen ... Bei der englischen Version handelt ... 91 % der Teilnehmer einer groß angelegten Asthmaumfrage halten ... laut GINA [*] -Definition [1] als kontrolliert gelten ... Asthma generell einer von vier Denkweisen zugeordnet werden können, ...
Breaking Biology Technology:See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7
... at the Drake Hotel in Chicago, about 130 people ... due diligence providers gathered at the M&A Advisor conference ... markets ($10 million to $1 billion) of financing and ... of your brand and intellectual property" to "due diligence: ...
... Corp. has raised approximately $137 million in net proceeds ... global manufacturer of identification solutions, including signs and labels, issued ... per share. The company intends to use the net proceeds ... facility and for general corporate purposes, including potential future acquisitions. ...
... Corp ., the banking and payments technology subsidiary of ... final stages of acquiring VICOR, Inc. , a ... ,VICOR is being pursued, in part, to enable Metavante ... financial institutions so they can address the need to ...
Cached Biology Technology:Some great insights into the current Mergers & Acquisitions Market 2Some great insights into the current Mergers & Acquisitions Market 3Some great insights into the current Mergers & Acquisitions Market 4Some great insights into the current Mergers & Acquisitions Market 5
(Date:5/24/2013)... the immune system to combat metastatic cancer , ... destruction by the immune system. Stimulation of the immune ... are many factors that cause the immune system to ... that function to suppress the immune system response. In ... , researchers led by Ronald Levy at Stanford University ...
(Date:5/24/2013)... After studying noise in one French Quarter neighborhood ... levels exceeded municipal ordinances, Annette Hurley, PhD, Assistant Professor ... and Eric Arriaga, a third-year LSUHSC doctor of audiology ... their own hearing health. Their case study is published ... Hearing Practice Management ., "An important part of an ...
(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) discovery ... grasses , Within the genome of each species, ... little change in position and sequence over millions of ... of these evolutionarily stable sequences, so-called conserved noncoding sequences ... genes or the condensation of chromosomes, but the function ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8Please do try this at home 2Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3
... may be a crucial factor underlying the development of emphysema, ... found that in mice that have short telomeres, there was ... cigarette smoke," said Mary Armanios, MD, assistant professor of oncology ... appears online ahead of the print edition of the ...
... breakthrough in the development of a cable that will make ... quantum wire (AQW) will be a weave of metallic nanotubes ... It will be an ideal replacement for the nation,s copper-based ... 100 miles of transmission, said Rice chemist Andrew R. Barron, ...
... and singer Julie Andrews lost her singing voice following surgery ... to Steven Zeitels, a professor of laryngeal surgery at Harvard ... develop a new type of material that could be implanted ... 2002, he enlisted the help of MIT,s Robert Langer, the ...
Cached Biology News:Research links telomere length to emphysema risk 2'Amplified' nanotubes may power the future 2'Amplified' nanotubes may power the future 3New material could offer hope to those with no voice 2New material could offer hope to those with no voice 3
iNOS/NOS Type II Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 150 µg Consult technical datasheet for details....
Cell Culture Flask, 75 cm, treated polystyrene...
Cell Culture Flask, 75 cm, nontreated polystyrene...
... virtually every research laboratory, the revolutionary Luminex ... accurately, inexpensively and in real time enhancing ... analysis system includes the Luminex 100, the ... xMAP technology which enables you to simultaneously ...
Biology Products: